Chordia Therapeutics Inc was launched in Shonan Health Innovation Park at Takeda Pharmaceutical Company Limited Shonan site.
We seek to discover new therapeutic options for areas of high unmet medical needs in oncology.

November, 2017
Chordia Therapeutics Inc.
CEO Hiroshi Miyake, Ph.D.